The purchase involved 2,510 shares at $46.92 per share.
The shares were acquired directly, with no reported indirect holdings or derivative conversions.
The stock price has underperformed in 2026, falling 14.7%.
Samuel Jonas Poletti, Chief Strategy & M&A Officer at Amrize (NYSE:AMRZ), purchased 2,510 shares of the company on Aug. 17, 2026, according to a SEC Form 4 filing.
| Metric | Value |
|---|---|
| Transaction value | $117,769 |
| Shares purchased | 2,510 |
| Post-transaction shares (directly held) | 10,155 |
| Post-transaction value | $464,388 |
Transaction value based on SEC Form 4 weighted average purchase price ($46.92); post-transaction value based on Aug. 17, 2026 market close ($45.73).
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-08-17) | $45.73 |
| Market Capitalization | $24.2 billion |
| Revenue (TTM) | $12.2 billion |
| Net Income (TTM) | $1.2 billion |
Amrize operates as a leading construction materials provider with a market capitalization of $24.2 billion and annual revenue of $12.2 billion (TTM), serving the essential infrastructure and construction sectors across North America. The company's dual-segment business model, which combines commodity-based building materials with higher-margin engineered building envelope systems, provides operational diversification and exposure to both cyclical and defensive construction end-markets. With 19,000 employees and established operations across North America and Canada, Amrize maintains a competitive position through integrated supply chains and comprehensive product offerings that address the full spectrum of construction material requirements.
The Amrize stock price has struggled to find its footing over the last year, with shares down 14.7%. In comparison, during the same period, the S&P 500 is up 19.2%. In the company's 2026 second-quarter earnings call, management pointed to issues with higher costs for diesel, freight, and materials, which are impacting profitability. However, Poletti's share purchase could be viewed as a bullish signal for shareholders. It could be a sign that, while the company is facing certain cost pressures now, the insider believes those will eventually subside. That's backed up by the number of shares Poletti bought (2,510), which increased his stake by 33%.
To pair with the insider's recent purchase, analysts are slightly bullish on Amrize. Of the 27 who cover the stock, 59% have a buy rating, 37% a hold, and 4% a sell, according to CNN. From those 27 analysts, the median one-year price target is $57, which would be a 28.7% from the stock price as of this writing. The highest price target in the group is $70, and even the lowest, $48, would still be a gain over the current price.
Jack Delaney has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.